Sign in

    Gary S. Guthart

    CEO at Intuitive Surgical Inc
    Board
    Since January 2010
    Age
    58 years
    Education
    Holds a B.S. in Engineering from the University of California, Berkeley, and an M.S. and Ph.D. in Engineering Science from the California Institute of Technology.
    Tenure
    Joined ISRG in April 1996 and has held roles including COO, President, and currently serves as CEO since January 2010.

    Also at Intuitive Surgical Inc

    DJR
    David J. Rosa
    President
    BD
    Bob DeSantis
    EVP, Chief Strategy and Corporate Operations Officer
    GHL
    Gary H. Loeb
    SVP, General Counsel, and Chief Compliance Officer

    About

    Dr. Guthart has built a distinguished career characterized by a strong foundation in engineering and innovation. He started his professional journey by contributing to the development of early computer-enhanced surgical technologies during his tenure with SRI International, which set the stage for a groundbreaking career in the med-tech industry.

    At ISRG, his leadership has been pivotal in driving the evolution of robotic-assisted surgery. His forward-thinking vision and operational expertise helped propel the development and commercialization of transformative surgical systems, significantly impacting patient outcomes and advancing minimally invasive procedures.

    Beyond his executive role, Dr. Guthart has demonstrated a commitment to shaping the broader biomedical landscape through influential board positions at major companies such as Illumina and Affymetrix. His multifaceted contributions underscore a career marked by both technical prowess and strategic leadership.

    $ISRG Performance Under Gary S. Guthart

    Past Roles

    OrganizationRoleDate RangeDetails
    Intuitive Surgical, Inc. President July 2007 - May 2023 Held concurrently with other roles until May 2023
    Intuitive Surgical, Inc. Chief Operating Officer February 2006 - July 2007 Role ended upon promotion to President
    Intuitive Surgical, Inc. Core Team Member April 1996 - February 2006 Part of the core team developing foundation technology for computer-enhanced surgery
    SRI International (formerly Stanford Research Institute) Core Team Member N/A Developed foundation technology for computer-enhanced surgery

    External Roles

    OrganizationRoleDate RangeDetails
    Illumina, Inc. Board of Directors Since December 2017 N/A

    Fixed Compensation

    Data from  FY 2023
    Component NameAmountPayment ScheduleAdditional Details
    Base Salary$980,000Annual (as of April 1, 2023)11.4% increase from prior year
    All Other Compensation$56,267AnnualIncludes various components (breakdown not detailed)

    Performance Compensation

    Data from  FY 2023

    Annual Performance-Based Cash Bonus

    MetricThresholdTargetMaximumWeightAdditional Details
    Adjusted Operating Income (AOI)$2.198B $2.381B $2.775B 50%Defined as operating income excluding CIP expense, share-based comp., and other adjustments
    Company Performance GoalsConfidential Confidential Confidential 50%Categories: Support Our Customers, Innovation & Operational Excellence, Quality & Regulatory, Financial
    CIP Funding LevelN/AN/AN/AN/A107.1% overall funding; with AOI at 106.5% and Goals at 107.6%
    Bonus OpportunityN/A150% of Base Salary 187.5% of Base Salary N/ATarget Bonus: $1,432,500, Maximum Bonus: $1,790,625

    Equity Incentive Plan Awards

    ComponentGrant DateGrant Date Fair ValueGrant Date Stock PriceShares/UnitsVesting SchedulePerformance Metrics / Conditions
    Performance Stock Units (PSUs)Feb 28, 2023 $5,774,416<br>(Performance: $4,027,515; Market: $1,746,901) $229.39 Target: 21,069<br>Threshold: 15,802<br>Max: 26,336 Vest on third anniversary (Feb 28, 2026), contingent on performance and continued service Metrics: 2022-2024 Procedure Count Growth (33.3%), 2022-2025 Procedure Count Growth (33.3%), and Relative TSR (33.3%)
    Restricted Stock Units (RSUs)Feb 28, 2023 $2,416,394 $229.39 10,534 RSUs Time-based vesting in 1/4 increments over four years Not performance-based; vests solely over time
    Stock OptionsFeb 28 & Aug 10, 2023 Feb 28: $1,137,582<br>Aug 10: $1,304,482 Feb 28: $229.39<br>Aug 10: $304.67 15,801 options each grant Likely multi-year vesting; initial tranche (e.g., 6/48ths vesting after 6 months) Performance indirectly influenced by the overall equity mix; details integrated with PSU metrics